STAT: FIRST OPINION

Peer Review Could Have Helped Short-circuit The Theranos Fake News Scandal

By:  Kevin Hrusovsky

Theranos had a product almost everyone could get behind: a revolutionary blood test that would allow individuals to quickly and easily access information about their health. Startups like Theranos rely on cutting-edge innovation, then leverage that innovation to attract investors. Now the company’s downfall is a signal to innovators, the public, and the media that we need more transparency and credibility built on peer-reviewed publications.

Read the complete article at:  https://www.statnews.com/2018/05/16/peer-review-short-circuit-theranos-scandal/